Quantum Genomics Société Anonyme (QNNTF PINK) stock market data APIs
$0.0992
0(0%)
as of July 2, 2025
Try our APIs with
free plan!
Quantum Genomics Société Anonyme Financial Data Overview
Price chart is built with
Anychart
Quantum Genomics Société Anonyme, a healthtech company, develops of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.
Prev. Close
0.0992
Open
0.0992
High
0.0992
Low
0.0992
52 wk Range
0.1-0.1
Market Cap
6 962 K
Shares Outstanding
69 619 K
Revenue
10
EPS
-0.1363
Beta
0.161
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Quantum Genomics Société Anonyme data using free add-ons & libraries
Get Quantum Genomics Société Anonyme Fundamental Data
Quantum Genomics Société Anonyme Fundamental data includes:
- Net Revenue: 10
- EBITDA: -1 470 237
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Quantum Genomics Société Anonyme News
New
Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments
Firibastat efficacy non-significant versus placebo The REFRESH study and the development of firibastat in cardiology have been stoppedCash of 11 million euros allotted to the development of new innova...
Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments
Quantum Genomics Firibastat efficacy non-significant versus placebo The REFRESH study and the development of firibastat in cardiology have been stopped Cash of 11 million euros allotted to the devel...
Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share
PARIS, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal products...
Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share
Quantum Genomics PARIS, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of me...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
